Concerns Align on the DEA Telemedicine Rule
Over 35,000 Americans provided comments on the Drug Enforcement Administration's (DEA) proposed rule, "Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation." In comment letters responding to the DEA's proposed rule, hundreds of key stakeholders highlighted the need for a special registration for telemedicine and [...]